Health Team

US needs 'simpler studies' to speed coronavirus response, Duke expert says

Dr. Mark McClellan, director of the Margolis Center for Health Policy at Duke University and a former FDA commissioner, says U.S. regulations on clinical trials need to be streamlined so treatments for coronavirus can move more quickly from the lab to the marketplace.